ESR1 and cancer: In particular, IGF-1 has been shown to transactivate the promoter sequence of GPER and to upregulate the expression of GPER at both the mRNA and protein levels in ERα-positive breast (MCF-7) and endometrial (Ishikawa) cancer cells (120).